NasdaqGS - Nasdaq Real Time Price USD
Acumen Pharmaceuticals, Inc. (ABOS)
0.9800
-0.0600
(-5.77%)
As of 1:58:47 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
238,992
310,125
196,587
230,330
Total Liabilities Net Minority Interest
57,176
43,152
7,812
5,147
Total Equity Gross Minority Interest
181,816
266,973
188,775
225,183
Total Capitalization
210,265
294,310
188,775
225,183
Common Stock Equity
181,816
266,973
188,775
225,183
Capital Lease Obligations
283
1,150
105
--
Net Tangible Assets
181,816
266,973
188,775
225,183
Working Capital
150,699
233,644
172,517
193,514
Invested Capital
210,265
294,310
188,775
225,183
Tangible Book Value
181,816
266,973
188,775
225,183
Total Debt
28,732
28,487
105
--
Share Issued
60,079.7780
57,910.4610
41,025.0620
40,473.2700
Ordinary Shares Number
60,079.7780
57,910.4610
41,025.0620
40,473.2700
12/31/2021 - 7/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACRV Acrivon Therapeutics, Inc.
1.2903
-9.13%
ACXP Acurx Pharmaceuticals, Inc.
0.3608
-9.98%
ITOS iTeos Therapeutics, Inc.
6.66
-7.31%
TYRA Tyra Biosciences, Inc.
9.69
-7.76%
SLRN Acelyrin, Inc.
2.4150
-4.92%
NMRA Neumora Therapeutics, Inc.
0.6901
-1.08%
ANTX AN2 Therapeutics, Inc.
1.1400
-5.79%
DSGN Design Therapeutics, Inc.
3.6000
-17.43%
CLYM Climb Bio Inc
1.2100
-3.20%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2550
-7.72%